Vilaplana J, Romaguera C

Language: Spanish
References: 10
Page: 242-243
PDF size: 167.08 Kb.

Text Extraction

No abstract

REFERENCES

1. Massó JM, Villar AM, Conde JR, Martorell J. Mechanism of anti-inflammatory action of fepradinol. Arzneimittelforschung 1994; 44:68-74.

2. 2.Massó JM, Villar AM, Conde JR, Martorell J. Effects of fepradinol on rat acute models of vascular permeability and leucocyte migration. Agents Actions 1994;42: 118-22.

3. 3.Izu R, Aguirre A, Irazábal B, Goday J, Diaz-Pérez JL. Allergic contact dermatitis from fepradinol. Contact Dermatitis 1992;27: 266-7.

4. 4.Ortiz-Frutos FJ, Hergueta JP, Quintana I, Zarco C, Iglesias L. Allergic contact dermatitis from fepradinol: report of 4 cases and review ofthe literature. Contact Dermatitis 1994;31: 193-5.

5. 5.Rodríguez Granados T, Pineiro G, De la Torre C, Cruces Prado MJ. Photoallergic contact dermatitis from fepradinol. Contact Dermatitis 1998;39:194-5.

6. Santos-Briz A, Antúnez P, Muñoz E, Morán M, Fernández E, Unamuno P. Vascular- occlusive contact dermatitis from fepradinol. Contact Dermatitis 2004; 50:44-6.

7. 7.Barranco R, Rodríguez A, De Barrio M, Trujillo MJ, De Frutos C, Matheu V, Tornero P, Herrero T. Sympathomimetic drug allergy: cross- reactivity study by patch test. Am J Clin Dermatol 2004;5:351-5.

8. 8.Goday JJ, Yanguas I, González-Guemes M, Oleaga JM, Ilardia R, Soloeta R. No evidence of cross-reaction between fepradinol and other phenylethanolamines. Contact Dermatitis 1997;36:170-1.

9. Gonzalo MA, Revenga F. Multiple cutaneous sensitization to nonsteroidal anti-inflammatory drugs. Dermatology 1996;193:59-60.

10. 10.Schnuch A. Fepradinol allergy: possibly a case of unnoticed cross-reaction due to misclassification. Contact Dermatitis 1994; 30:243-5.